Pasar al contenido principal

DESARROLLO DE NANOMEDICINAS PARA TERAPIAS ANTITUMORALES E INMUNOSUPRESORAS

SAF2014-54057-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polyethylenimine-coated SPION exhibits potential intrinsic anti-metastatic properties inhibiting migration and invasion of pancreatic tumor cells

  • Mulens-Arias, Vladimir
  • Rojas, José Manuel
  • Pérez-Yagüe, Sonia
  • Morales, María Del Puerto
  • Barber, Domingo F.
Due to its aggressive behavior, pancreatic cancer is one of the principal causes of cancer-related deaths. The highly metastatic potential of pancreatic tumor cells demands the development of more effective anti-metastatic approaches for this disease. Although polyethylenimine-coated superparamagnetic iron oxide nanoparticles (PEI-coated SPIONs) have been studied for their utility as transfection agents, little is known of their effect on tumor cell biology. Here we demonstrated that PEI-coated SPIONs have potent inhibitory effects on pancreatic tumor cell migration/invasion, through inhibition of Src kinase and decreased expression of MT1-MMP and MMP2 metalloproteinases. When treated with PEI-coated SPIONs, the pancreatic tumor cell line Pan02 showed reduced invadosome density and thus, a decrease in their ability to invade through basement membrane. These nanoparticles temporarily downmodulated microRNA-21, thereby upregulating the cell migration inhibitors PTEN, PDCD4 and Sprouty-1. PEI-coated SPIONs thus show intrinsic, possibly anti-metastatic properties for modulating pancreatic tumor cell migration machinery, which indicates their potential as anti-metastatic agents for treatment of pancreatic cancer., VMA is a PhD fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB). JMR was supported by a JAEdoc contract from the Spanish Ministry of Economy and Competitiveness (MINECO), co-financed by the European Social Fund. This work was supported in part by grants from the MINECO (SAF-2011-23639 and SAF-2014-54057-R to DFB; MAT2011-23641 to MPM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Analysis of the intra-lysosomal degradative interactome of magnetic nanoparticles

  • Portilla, Yadileiny
  • Sanz-Ortega, Laura
  • Pérez-Yagüe, Sonia
  • Paradela, Alberto
  • Morales, María Del Puerto
  • Barber, Domingo F.
Poster presented at the Nanomaterials Applied to Life Sciences (NALS), held in Gijón (Spain) on December 13-15th, 2017., Superparamagnetic iron oxide nanoparticles (SPIONs) have a great potential in the field of biomedicine due to its size and physical properties. Some examples would be the targeted drug release, the therapeutic hyperthermia and magnetic resonance imaging. The achieved success in lab assays using SPIONs led us to think that a fast transition to the clinic practice would occur, however this progress was slowed down by the lack of information regarding the molecular and cellular mechanisms that regulate the degradation of the nanoparticles, since it could affect the therapeutic efficiency of the SPIONs or its accumulation and toxicity on the long term. Once the SPIONs enter the body intravenously, they accumulate mostly in the liver and the spleen, where they are captured by macrophages of the reticuloendothelial system (1,2). SPIONs are all superparamagnetic but as time passes they gradually lose this magnetism, which suggests that the lysosome degrades SPIONs (2). Several studies, including those from our research group, have shown that after a period of time, these SPIONs are completely degraded. Such disposal processes point to a specific iron transformation metabolism in the lysosomes, which might be part of the cell¿s physiological iron degradation pathway or might imply the existence of another degenerative process in the cell interactome. To analyze this process and the proteins of the lysosome involved is the main goal of our ongoing research. The first step to achieve this objective is to isolate the organelles where the degradative process takes place: obtain the intra-lysosomal degradative interactome of the SPIONs. To achieve this, a magnetic isolation method was used. To corroborate that the obtained cellular fraction was rich on SPION loaded lysosomes, several techniques were performed: Western blot, microscopy (confocal, fluorescence and TEM) and mass spectrometry analysis. Western blot experiments showed that the sample was rich in LAMP 1 protein, which is typically found in the lysosome membrane, which confirmed that lysosomes were clearly present. Once obtained, we tested its integrity via microscopy. In fluorescence and confocal microscopy, the areas in which SPION appeared were surrounded by lysosomes. In a subsequent analysis by TEM, we observed full lysosomes. This cell fraction was then used for proteomic analysis. It allowed us to obtain a first approximation for the description of the cellular interactome induced by treatment with SPIONs. In this experiment we validate the enrichment of the lysosomal fraction and identify possible proteins involved in the degradation of the nanoparticles. So far, a SPION-rich lysosome fraction has been isolated, which allow us to further study the process of degradation over time of the SPIONs and the proteins involved in it. This knowledge will contribute to make the use of the SPIONs on the clinical practice a reality and to develop a more efficient second generation of nanoparticles., This work was supported by an FPU grant (FPU15/06170) to YP and a Spanish Ministry of Economy and Competitiveness/FEDER grant (MINECO SAF-2014-54057-R) to DFB.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Understanding magnetic hyperthermia

  • Hernández Flores, Patricia
  • Talelli, Marina
  • Barber, Domingo F.
Poster presented at the Nanomaterials Applied to Life Sciences (NALS), held in Gijón (Spain) on December 13-15th, 2017., Magnetic hyperthermia (MH) is the selective temperature increase in tumour tissues preloaded with magnetic nanoparticles (MNP) able to release heat in response to application of an alternating magnetic field (AMF) in the radiofrequency range. Despite much research, the underlying mechanism as to how this treatment causes cell death remains unclear. To test whether the biological effects mediated by MNP under an AMF were caused by heat dissipation originated from MNP, we performed in vitro MH experiments using (3-aminopropyl)-triethoxysilane-coated MNP (APS-MNP) with different core sizes (6, 8 and 14 nm). Suspended in water, these MNP produce increasing amounts of heat in the presence of an AMF (30 mT maximum, 250 kHz). After characterizing the MNP, we studied cell viability and particle uptake by murine pancreatic adenocarcinoma Pan02 cells. We measured cytotoxicity using a colorimetric PrestoBlue assay, quantified intracellular MNP amounts by ICP-OES (inductively coupled plasma atomic emission spectroscopy), and visualized the MNP by TEM (transmission electron microscopy). In addition, we used the PrestoBlue assay to test the effect of MH treatment on cell viability. To complement these results, we analysed activation of the effector caspase-3 by Western blot, and studied changes in cell morphology by TEM. After AMF exposure, cell viability was reduced. TEM images showed morphological features of apoptosis, which was confirmed by caspase-3 activation. We nonetheless found that all three MNP showed similar results, despite their distinct heat-producing abilities. Comparison of mRNA Hspa1b levels (increased in stress conditions, including heat stress) showed increased expression not only by MNP-loaded cells but also by non-loaded control samples when exposed to AMF. Cells thus received heat from an external source, the copper coil that generated the AMF and was heated due to passage of the electric current. To resolve this difficulty, experimental settings were modified and MH experiments repeated, maintaining the culture medium temperature at 37 ºC throughout AMF application, thus excluding the effect of the heat generated by the coil. In the conditions of these new experimental settings, we found none of the previously observed effects, in agreement with results described in the literature [1,2]. In conclusion, in our experimental setting MH treatment only appears to have an effect when combined with external heating. Our goal now is to understand our system when applying magnetic hyperthermia under physiological temperature conditions., PHF received a pre-doctoral Severo Ochoa grant from the Department of Research, Development and Innovation, within the Spanish Ministry of Economy and Competitiveness (MINECO). MT received a JdC post-doctoral grant (JCI-2012-13159) from the MINECO. This work was supported by a grant from the MINECO (SAF-2014-54057-R to DFB).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Time-course assessment of the aggregation and metabolization of magnetic nanoparticles

  • Rojas, José Manuel
  • Gavilán, Helena
  • Dedo, Vanesa
  • Lorente-Sorolla, Eduardo
  • Sanz-Ortega, Laura
  • Silva, Gustavo B. da
  • Costo, Rocío
  • Pérez-Yagüe, Sonia
  • Talelli, Marina
  • Marciello, Marzia
  • Morales, María Del Puerto
  • Barber, Domingo F.
  • Gutiérrez, Lucía
To successfully develop biomedical applications for magnetic nanoparticles, it is imperative that these nanoreagents maintain their magnetic properties in vivo and that their by-products are safely metabolized. When placed in biological milieu or internalized into cells, nanoparticle aggregation degree can increase which could affect magnetic properties and metabolization. To evaluate these aggregation effects, we synthesized citric acid-coated iron oxide nanoparticles whose magnetic susceptibility can be modified by aggregation in agar dilutions and dextran-layered counterparts that maintain their magnetic properties unchanged. Macrophage models were used for in vitro uptake and metabolization studies, as these cells control iron homeostasis in the organism. Electron microscopy and magnetic susceptibility studies revealed a cellular mechanism of nanoparticle degradation, in which a small fraction of the particles is rapidly degraded while the remaining ones maintain their size. Both nanoparticle types produced similar iron metabolic profiles but these profiles differed in each macrophage model. Thus, nanoparticles induced iron responses that depended on macrophage programming. In vivo studies showed that nanoparticles susceptible to changes in magnetic properties through aggregation effects had different behavior in lungs, liver and spleen. Liver ferritin levels increased in these animals showing that nanoparticles are degraded and their by-products incorporated into normal metabolic routes. These data show that nanoparticle iron metabolization depends on cell type and highlight the necessity to assess nanoparticle aggregation in complex biological systems to develop effective in vivo biomedical applications. Statement of Significance Magnetic iron oxide nanoparticles have great potential for biomedical applications. It is however imperative that these nanoreagents preserve their magnetic properties once inoculated, and that their degradation products can be eliminated. When placed in a biological milieu nanoparticles can aggregate and this can affect their magnetic properties and their degradation. In this work, we showed that iron oxide nanoparticles trigger the iron metabolism in macrophages, the main cell type involved in iron homeostasis in the organism. We also show that aggregation can affect nanoparticle magnetic properties when inoculated in animal models. This work confirms iron oxide nanoparticle biocompatibility and highlights the necessity to assess in vivo nanoparticle aggregation to successfully develop biomedical applications., José M. Rojas was supported by a JAEdoc grant co-financed by the CSIC and the European Social Fund. Laura Sanz-Ortega receives a predoctoral FPU grant (13/05037) from the Spanish Ministry of Economy and Competitiveness. Marina Talelli received a JdC post-doctoral grant (JCI-2012-13159) from the Spanish Ministry of Economy and Competitiveness. Gustavo B. da Silva was beneficiary of a sandwich-PhD grant of the Brazilian agency CNPq (Science without borders – Process: 279444/2013-9). Lucía Gutiérrez was the beneficiary of a post-doctoral grant from the AXA Research Fund and also acknowledges financial support from the Ramón y Cajal subprogram (RYC-2014-15512). This work was supported in part by grants from the Spanish Ministry of Economy and Competitiveness (SAF-2011-23639 and SAF-2014-54057-R to DFB and MAT2014-52069-R to Sabino Veintemillas-Verdaguer).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8+ T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes

  • Sanz-Ortega, Laura
  • Portilla, Yadileiny
  • Pérez-Yagüe, Sonia
  • Barber, Domingo F.
[Background] Adoptive T cell-transfer (ATC) therapy is a highly promising cancer-treatment approach. However, in vivo-administered T cells tend to disperse, with only a small proportion reaching the tumour. To remedy this, magnetic targeting of T cells has been recently explored. Magnetic nanoparticles (MNPs) functionalised with antibodies were attached to effector T cells and magnetically recruited to tumour sites under MRI guidance. In this study, we investigated whether 3-aminopropyl-triethoxysilane (APS)-coated MNPs directly attached to CD8+ T cell membranes could also magnetically target and accumulate tumour-specific CD8+ T cells in solid tumours using an external magnetic field (EMF). As it has been shown that T cells associated with APS-coated MNPs are retained in lymph nodes (LNs), and tumour-draining LNs are the most common sites of solid-tumour metastases, we further evaluated whether magnetic targeting of APS-MNP-loaded CD8+ T cells could cause them to accumulate in tumour-draining LNs., [Results] First, we show that antigen-specific CD8+ T cells preserve their antitumor activity in vitro when associated with APS-MNPs. Next, we demonstrate that the application of a magnetic field enhanced the retention of APS-MNP-loaded OT-I CD8+ T cells under flow conditions in vitro. Using a syngeneic mouse model, we found similar numbers of APS-MNP-loaded OT-I CD8+ T cells and OT-I CD8+ T cells infiltrating the tumour 14 days after cell transfer. However, when a magnet was placed near the tumour during the transfer of tumour-specific APS-MNP-loaded CD8+ T cells to improve tumour infiltration, a reduced percentage of tumour-specific T cells was found infiltrating the tumour 14 days after cell transfer, which was reflected in a smaller reduction in tumour size compared to tumour-specific CD8+ T cells transferred with or without MNPs in the absence of a magnetic field. Nonetheless, magnet placement near the tumour site during cell transfer induced infiltration of activated tumour-specific CD8+ T cells in tumour-draining LNs, which remained 14 days after cell transfer., [Conclusions] The use of an EMF to improve targeting of tumour-specific T cells modified with APS-MNPs reduced the percentage of these cells infiltrating the tumour, but promoted the retention and the persistence of these cells in the tumour-draining LNs., This work was supported in part by Grants from the Spanish Ministry of Economy, Industry and Competitiveness (SAF-2014-54057-R and SAF-2017-82223-R to DFB). L Sanz-Ortega and Y Portilla receive predoctoral FPU Grants (FPU13/05037 and FPU15/06170 respectively) from the Spanish Ministry of Economy., We acknowledge support of the publication fee by the CSIC Open Access Support Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.

  • Sanz-Ortega, Laura
  • Rojas, José Manuel
  • Portilla, Yadileiny
  • Pérez-Yagüe, Sonia
  • Barber, Domingo F.
Adoptive cell transfer therapy is currently one of the most promising approaches for cancer treatment. This therapy has some limitations, however, such as the dispersion of in vivo-administered cells, causing only a small proportion to reach the tumor. Nanotechnological approaches could offer a solution for this drawback, as they can increase cell retention and accumulation in a region of interest. In particular, strategies employing magnetic nanoparticles (MNPs) to improve targeting of adoptively transferred T or NK cells have been explored in mice. In vivo magnetic retention is reported using the human NK cell line NK-92MI transfected with MNPs. Primary NK cells are nonetheless highly resistant to transfection, and thus we explore in here the possibility of attaching the MNPs to the NK cell surface to overcome this issue, and examine whether this association would affect NK effector functions. We assessed the attachment of MNPs coated with different polymers to the NK cell surface, and found that APS-MNP attached more efficiently to the NK-92MI cell surface. In association with MNPs, these cells preserved their main functions, exhibiting a continued capacity to degranulate, conjugate with and lyse target cells, produce IFN-γ, and respond to chemotactic signals. MNP-loaded NK-92MI cells were also retained in an in vitro capillary flow system by applying an EMF. A similar analysis was carried out in primary NK cells, isolated from mice, and expanded in vitro. These primary murine NK cells also maintained their functionality intact after MNP treatment and were successfully retained in vitro. This work therefore provides further support for using MNPs in combination with EMFs to favor specific retention of functional NK cells in a region of interest, which may prove beneficial to adoptive cell-therapy protocols., This work was supported in part by grants from the Spanish Ministry of Economy, Industry and Competitiveness (SAF-2014-54057-R and SAF-2017-82223-R to DB)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.

  • Sanz-Ortega, Laura
  • Rojas, José Manuel
  • Marcos, Ana
  • Portilla, Yadileiny
  • Stein, Jens V.
  • Barber, Domingo F.
BACKGROUND:T lymphocytes are highly dynamic elements of the immune system with a tightly regulated migration. T cell-based transfer therapies are promising therapeutic approaches which in vivo efficacy is often limited by the small proportion of administered cells that reaches the region of interest. Manipulating T cell localisation to improve specific targeting will increase the effectiveness of these therapies. Nanotechnology has been successfully used for localized release of drugs and biomolecules. In particular, magnetic nanoparticles (MNPs) loaded with biomolecules can be specifically targeted to a location by an external magnetic field (EMF). The present work studies whether MNP-loaded T cells could be targeted and retained in vitro and in vivo at a site of interest with an EMF. RESULTS:T cells were unable to internalize the different MNPs used in this study, which remained in close association with the cell membrane. T cells loaded with an appropriate MNP concentration were attracted to an EMF and retained in an in vitro capillary flow-system. MNP-loaded T cells were also magnetically retained in the lymph nodes after adoptive transfer in in vivo models. This enhanced in vivo retention was in part due to the EMF application and to a reduced circulating cell speed within the organ. This combined use of MNPs and EMFs did not alter T cell viability or function. CONCLUSIONS:These studies reveal a promising approach to favour cell retention that could be implemented to improve cell-based therapy., This work was supported in part by Grants from the Spanish Ministry of Economy, Industry and Competitiveness (SAF-2014-54057-R and SAF-2017-82223-R to DFB)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting

  • Sanz-Ortega, Laura
  • Rojas, José Manuel
  • Barber, Domingo F.
© 2020 by the authors., Adoptive cell transfer therapy is a promising anti-tumor immunotherapy in which effector immune cells are transferred to patients to treat tumors. However, one of its main limitations is the inefficient trafficking of inoculated effector cells to the tumor site and the small percentage of effector cells that remain activated when reaching the tumor. Multiple strategies have been attempted to improve the entry of effector cells into the tumor environment, often based on tumor types. It would be, however, interesting to develop a more general approach, to improve and facilitate the migration of specific activated effector lymphoid cells to any tumor type. We and others have recently demonstrated the potential for adoptive cell transfer therapy of the combined use of magnetic nanoparticle-loaded lymphoid effector cells together with the application of an external magnetic field to promote the accumulation and retention of lymphoid cells in specific body locations. The aim of this review is to summarize and highlight the recent findings in the field of magnetic accumulation and retention of effector cells in tumors after adoptive transfer, and to discuss the possibility of using this approach for tumor targeting with chimeric antigen receptor (CAR) T-cells., This research was supported in part by Grants from the Spanish Ministry of Economy, Industry and Competitiveness (SAF-2014-54057-R and SAF-2017-82223-R to Domingo F. Barber). Laura Sanz-Ortega received a predoctoral FPU Grant (FPU13/05037) from the Spanish Ministry of Economy, Industry and Competitiveness. José Manuel Rojas is supported by the European Commission-funded VetBioNet INFRAIA-731014 project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis

  • Mulens-Arias, Vladimir
  • Rojas, José Manuel
  • Sanz-Ortega, Laura
  • Portilla, Yadileiny
  • Pérez-Yagüe, Sonia
  • Barber, Domingo F.
Endothelial cells are essential to tumor vascularization and impairing their activity can potentially limit tumor growth. Since polyethylenimine (PEI)-coated superparamagnetic iron oxide nanoparticles (SPIONs) are bioactive nanosystems that modulate inflammatory macrophage responses and limit tumor cell invasion, we evaluated their effects on endothelial cell angiogenesis. PEI-SPION triggered proinflammatory gene profiles in a murine endothelial cell line and in primary human umbilical cord vein endothelial cells (HUVECs). These nanoparticles impaired endothelial cell migration and inhibited HUVEC tube formation. Magnetically tumor-targeted PEI-SPIONs reduced tumor vessel numbers and promoted intratumor macrophage infiltration in a tumor xenograft model. PEI-SPION treatment impaired M2 macrophage-promoted tube formation and affected HUVEC cytoskeleton by limiting Src and Cortactin activation. These mechanisms could contribute to PEI-SPION in vitro and in vivo antiangiogenic potential. These data confirm that PEI-SPION administration and application of a localized magnetic field could offer an affordable anti-angiogenic anti-tumoral targeted treatment that would complement other therapies., LSO and YP receive predoctoral FPU grants (FPU13/05037 and FPU15/06170 respectively) from the Spanish Ministry of Economy and Competitiveness, VMA was a PhD fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB), JMR was supported by a JAEdoc grant co-financed by the CSIC and the European Social Fund. This work was supported in part by grants from the Spanish Ministry of Economy and Competitiveness (SAF-2014-54057-R and SAF-2017-82223-R to DFB).